LIB-01(LIB-01) - 在研适应症：勃起功能障碍，早泄_专利_临床

概要

基本信息

药物类型

小分子化药

别名

LIB-01

靶点-

作用方式-

作用机制-

治疗领域

泌尿生殖系统疾病

在研适应症

勃起功能障碍早泄

非在研适应症-

原研机构

Dicot Pharma AB

在研机构

Dicot Pharma AB

非在研机构-

权益机构-

最高研发阶段临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

2

项与 LIB-01 相关的临床试验

NCT06703840

/ Completed临床2期

A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erectile Dysfunction

The goal of this clinical trial is to learn if the drug LIB-01 works to treat erectile dysfunction in male adults. It will also learn about the safety of the drug LIB-01. The main questions it aims to answer are:
* Does the drug LIB-01 improve erectile function in males with erectile dysfunction?
* What medical problems do participants have when taking the drug LIB-01? Researchers will compare the drug LIB-01 to a placebo (a look-alike substance that contains no drug) to see if the drug LIB-01 works to treat erectile dysfunction.
Participants will:
* Take the drug LIB-01 or a placebo every day for 3 days
* Visit the clinic every week for 4 weeks, and at 8 weeks, for checkups and tests

开始日期2024-11-08

申办/合作机构

Dicot Pharma AB

NCT06324006

/ Completed临床1期

A Phase 1, Randomized, Double-blind, Parallel and Placebo-controlled Single and Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of LIB-01 in Healthy Participants.

The goal of this clinical trial is to learn about the safety, tolerability and pharmacokinetics of LIB-01 in healthy male participants. The main questions it aims to answer are:
* How safe and tolerable is LIB-01 when given once or repeatedly at different dose levels.
* What are the pharmacokinetic characteristics of LIB-01
Participants will receive LIB-01 and be followed up for safety and pharmacokinetics by:
* Adverse events
* ECG
* Blood sampling for laboratory parameters and pharmacokinetic analysis

开始日期2023-08-25

申办/合作机构

Dicot Pharma AB

100 项与 LIB-01 相关的临床结果

登录后查看更多信息

100 项与 LIB-01 相关的转化医学

登录后查看更多信息

100 项与 LIB-01 相关的专利（医药）

登录后查看更多信息

100 项与 LIB-01 相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

登录

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
勃起功能障碍	临床2期	丹麦	Dicot Pharma AB	2024-11-08
勃起功能障碍	临床2期	荷兰	Dicot Pharma AB	2024-11-08
勃起功能障碍	临床2期	瑞典	Dicot Pharma AB	2024-11-08
早泄	药物发现	瑞典	Dicot Pharma AB	2026-05-01